{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:37:16Z","timestamp":1793155036059,"version":"4.5.0"},"reference-count":114,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004742","name":"National Academy of Sciences of Ukraine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004742","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007684","name":"Ministry of Education and Science of Ukraine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007684","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.gene.2015.08.009","type":"journal-article","created":{"date-parts":[[2015,8,8]],"date-time":"2015-08-08T08:00:08Z","timestamp":1439020808000},"page":"193-203","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":302,"title":["Pitfalls of the MTT assay: Direct and off-target effects of inhibitors can result in over\/underestimation of cell viability"],"prefix":"10.1016","volume":"574","author":[{"given":"A.A.","family":"Stepanenko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.V.","family":"Dmitrenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gene.2015.08.009_bb0005","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.molcel.2011.01.001","article-title":"FKBP12 binds to acylated H-ras and promotes depalmitoylation","volume":"41","author":"Ahearn","year":"2011","journal-title":"Mol. Cell"},{"key":"10.1016\/j.gene.2015.08.009_bb0010","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/10915810500488361","article-title":"Cholesterol interferes with the MTT assay in human epithelial-like (A549) and endothelial (HLMVE and HCAE) cells","volume":"25","author":"Ahmad","year":"2006","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.gene.2015.08.009_bb0015","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/nbt.2017","article-title":"Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity","volume":"29","author":"Anastassiadis","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.gene.2015.08.009_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2014.04.010","article-title":"Kinomic exploration of temozolomide and radiation resistance in Glioblastoma multiforme xenolines","author":"Anderson","year":"2014","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.gene.2015.08.009_bb0025","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.18632\/oncotarget.1814","article-title":"Linking off-target kinase pharmacology to the differential cellular effects observed among PARP inhibitors","volume":"5","author":"Antol\u00edn","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.gene.2015.08.009_bb0030","first-page":"143","article-title":"Pharmacological inhibitors of JNK and ERK kinases SP600125 and U0126 are not appropriate tools for studies of drug metabolism because they activate aryl hydrocarbon receptor","volume":"27","author":"Bachleda","year":"2008","journal-title":"Gen. Physiol. Biophys."},{"key":"10.1016\/j.gene.2015.08.009_bb0035","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/BJ20070797","article-title":"The selectivity of protein kinase inhibitors: a further update","volume":"408","author":"Bain","year":"2007","journal-title":"Biochem. J."},{"key":"10.1016\/j.gene.2015.08.009_bb0040","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.semcdb.2014.09.024","article-title":"The structural basis for mTOR function","volume":"36","author":"Bareti\u0107","year":"2014","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.gene.2015.08.009_bb0045","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1038\/sj.onc.1208461","article-title":"Chronic myeloid leukaemia: an investigation into the role of Bcr-Abl-induced abnormalities in glucose transport regulation","volume":"24","author":"Barnes","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.gene.2015.08.009_bb0050","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0304-3835(03)00157-5","article-title":"Enhanced MTT-reducing activity under growth inhibition by resveratrol in CEM-C7H2 lymphocytic leukemia cells","volume":"195","author":"Bernhard","year":"2003","journal-title":"Cancer Lett."},{"key":"10.1016\/j.gene.2015.08.009_bb0055","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1387-2656(05)11004-7","article-title":"Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction","volume":"11","author":"Berridge","year":"2005","journal-title":"Biotechnol. Annu. Rev."},{"key":"10.1016\/j.gene.2015.08.009_bb0060","article-title":"Metabolic effects of resveratrol: addressing the controversies","author":"Bitterman","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.gene.2015.08.009_bb0065","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1667\/RR3070.1","article-title":"Unraveling the mechanisms behind the enhanced MTT conversion by irradiated breast cancer cells","volume":"179","author":"Blockhuys","year":"2013","journal-title":"Radiat. Res."},{"key":"10.1016\/j.gene.2015.08.009_bb0070","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.leukres.2009.01.040","article-title":"The metabolic consequences of imatinib mesylate: changes on glucose, lypidic and bone metabolism","volume":"33","author":"Breccia","year":"2009","journal-title":"Leuk. Res."},{"key":"10.1016\/j.gene.2015.08.009_bb0075","doi-asserted-by":"crossref","first-page":"6033","DOI":"10.1021\/pr1008527","article-title":"Proteomics analysis of cellular imatinib targets and their candidate downstream effectors","volume":"9","author":"Breitkopf","year":"2010","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.gene.2015.08.009_bb0080","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1055\/s-2002-32073","article-title":"Interference of plant extracts, phytoestrogens and antioxidants with the MTT tetrazolium assay","volume":"68","author":"Bruggisser","year":"2002","journal-title":"Planta Med."},{"key":"10.1016\/j.gene.2015.08.009_bb0085","first-page":"935","article-title":"Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia","volume":"8","author":"Cohen","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.gene.2015.08.009_bb0090","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/nbt.1990","article-title":"Comprehensive analysis of kinase inhibitor selectivity","volume":"29","author":"Davis","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.gene.2015.08.009_bb0095","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.febslet.2004.11.084","article-title":"PD98059 and U0126 activate AMP-activated protein kinase by increasing the cellular AMP:ATP ratio and not via inhibition of the MAP kinase pathway","volume":"579","author":"Dokladda","year":"2005","journal-title":"FEBS Lett."},{"key":"10.1016\/j.gene.2015.08.009_bb0100","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.drup.2007.02.003","article-title":"Cancer drug resistance: the central role of the karyotype","volume":"10","author":"Duesberg","year":"2007","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.gene.2015.08.009_bb0105","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2174\/1389203715666140331113753","article-title":"Molecular chaperone activity and biological regulatory actions of the TPR-domain immunophilins FKBP51 and FKBP52","volume":"15","author":"Erlejman","year":"2014","journal-title":"Curr. Protein Pept. Sci."},{"key":"10.1016\/j.gene.2015.08.009_bb0110","first-page":"481","article-title":"MCF-7 cell cycle arrested at G1 through ursolic acid, and increased reduction of tetrazolium salts","volume":"16","author":"Es-Saady","year":"1996","journal-title":"Anticancer Res."},{"key":"10.1016\/j.gene.2015.08.009_bb0115","doi-asserted-by":"crossref","first-page":"e76505","DOI":"10.1371\/journal.pone.0076505","article-title":"MEK inhibitor U0126 reverses protection of axons from Wallerian degeneration independently of MEK-ERK signaling","volume":"8","author":"Evans","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.gene.2015.08.009_bb0120","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1038\/sj.leu.2403861","article-title":"Induction of centrosome and chromosome aberrations by imatinib in vitro","volume":"19","author":"Fabarius","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.gene.2015.08.009_bb0125","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1365-2141.2007.06678.x","article-title":"Centrosome aberrations after nilotinib and imatinib treatment in vitro are associated with mitotic spindle defects and genetic instability","volume":"138","author":"Fabarius","year":"2007","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.gene.2015.08.009_bb0130","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.3324\/haematol.12793","article-title":"Centrosome aberrations and G1 phase arrest after in vitro and in vivo treatment with the SRC\/ABL inhibitor dasatinib","volume":"93","author":"Fabarius","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.gene.2015.08.009_bb0135","doi-asserted-by":"crossref","first-page":"18623","DOI":"10.1074\/jbc.273.29.18623","article-title":"Identification of a novel inhibitor of mitogen-activated protein kinase kinase","volume":"273","author":"Favata","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.gene.2015.08.009_bb0140","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.tiv.2009.02.007","article-title":"Mesoporous silica nanoparticles enhance MTT formazan exocytosis in HeLa cells and astrocytes","volume":"23","author":"Fisichella","year":"2009","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.gene.2015.08.009_bb0145","doi-asserted-by":"crossref","first-page":"966","DOI":"10.4161\/cbt.12.11.18136","article-title":"A metabolic perturbation by U0126 identifies a role for glutamine in resveratrol-induced cell death","volume":"12","author":"Freeman","year":"2011","journal-title":"Cancer Biol. Ther."},{"issue":"178","key":"10.1016\/j.gene.2015.08.009_bb0150","first-page":"180","article-title":"Serum albumin leads to false-positive results in the XTT and the MTT assay","volume":"43","author":"Funk","year":"2007","journal-title":"Biotechniques"},{"key":"10.1016\/j.gene.2015.08.009_bb0155","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.bbrc.2014.06.105","article-title":"Rapamycin-binding FKBP25 associates with diverse proteins that form large intracellular entities","volume":"450","author":"Galat","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.gene.2015.08.009_bb0160","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.ijbiomac.2014.05.060","article-title":"Diversified targets of FKBP25 and its complex with rapamycin","volume":"69","author":"Galat","year":"2014","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.gene.2015.08.009_bb0165","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/cdd.2009.44","article-title":"Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes","volume":"16","author":"Galluzzi","year":"2009","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.gene.2015.08.009_bb0170","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1600-0609.2010.01459.x","article-title":"Detection of centrosome aberrations in disease-unrelated cells from patients with tumor treated with tyrosine kinase inhibitors","volume":"85","author":"Giehl","year":"2010","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.gene.2015.08.009_bb0175","doi-asserted-by":"crossref","first-page":"6661","DOI":"10.1158\/1078-0432.CCR-04-0039","article-title":"Imatinib (STI571)-mediated changes in glucose metabolism in human leukemia BCR-ABL-positive cells","volume":"10","author":"Gottschalk","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.gene.2015.08.009_bb0180","article-title":"Off-target effects of BCR-ABL and JAK2 inhibitors","author":"Green","year":"2013","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.gene.2015.08.009_bb0185","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1006\/bbrc.1994.1199","article-title":"Rottlerin, a novel protein kinase inhibitor","volume":"199","author":"Gschwendt","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.gene.2015.08.009_bb0190","doi-asserted-by":"crossref","first-page":"e42863","DOI":"10.1371\/journal.pone.0042863","article-title":"The proteolytic activity of separase in BCR-ABL-positive cells is increased by imatinib","volume":"7","author":"Haa\u00df","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.gene.2015.08.009_bb0195","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.mce.2014.07.015","article-title":"Influence of mTOR in energy and metabolic homeostasis","volume":"397","author":"Haissaguerre","year":"2014","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.gene.2015.08.009_bb9000","first-page":"195","article-title":"Limitations of the use of MTT assay for screening in drug discovery","volume":"19","author":"Han","year":"2010","journal-title":"J. of Chinese Pharma. Sci."},{"key":"10.1016\/j.gene.2015.08.009_bb0200","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1080\/10428190801896103","article-title":"Target spectrum of the BCR-ABL inhibitors imatinib, nilotinib and dasatinib","volume":"49","author":"Hantschel","year":"2008","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.gene.2015.08.009_bb0205","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1471-4159.2012.07781.x","article-title":"Distinct molecular mechanisms of acquired resistance to temozolomide in glioblastoma cells","volume":"122","author":"Happold","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.gene.2015.08.009_bb0210","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.4161\/cc.25508","article-title":"FKBPs and the Akt\/mTOR pathway","volume":"12","author":"Hausch","year":"2013","journal-title":"Cell Cycle"},{"key":"10.1016\/j.gene.2015.08.009_bb0215","doi-asserted-by":"crossref","first-page":"R102","DOI":"10.1186\/bcr3043","article-title":"Pleurocidin-family cationic antimicrobial peptides are cytolytic for breast carcinoma cells and prevent growth of tumor xenografts","volume":"13","author":"Hilchie","year":"2011","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.gene.2015.08.009_bb0220","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1021\/tx3001708","article-title":"Particle-induced artifacts in the MTT and LDH viability assays","volume":"25","author":"Holder","year":"2012","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.gene.2015.08.009_bb0225","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.semcdb.2014.08.004","article-title":"mTORC1 signaling controls multiple steps in ribosome biogenesis","volume":"36","author":"Iadevaia","year":"2014","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.gene.2015.08.009_bb0230","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/bjc.1989.306","article-title":"The MTT assay underestimates the growth inhibitory effects of interferons","volume":"60","author":"Jabbar","year":"1989","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.gene.2015.08.009_bb0235","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/2008-2231-22-18","article-title":"Unraveling the cytotoxic potential of Temozolomide loaded into PLGA nanoparticles","volume":"22","author":"Jain","year":"2014","journal-title":"Daru"},{"key":"10.1016\/j.gene.2015.08.009_bb0240","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nrd3373","article-title":"Cell death assays for drug discovery","volume":"10","author":"Kepp","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.gene.2015.08.009_bb0245","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/gtc.12022","article-title":"Activity-based kinase profiling of approved tyrosine kinase inhibitors","volume":"18","author":"Kitagawa","year":"2013","journal-title":"Genes Cells"},{"key":"10.1016\/j.gene.2015.08.009_bb0250","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1476-5381.2009.00345.x","article-title":"Metabolic characteristics of imatinib resistance in chronic myeloid leukaemia cells","volume":"158","author":"Klawitter","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.gene.2015.08.009_bb0255","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1158\/1078-0432.CCR-08-3291","article-title":"Abnormalities in glucose uptake and metabolism in imatinib-resistant human BCR-ABL-positive cells","volume":"15","author":"Kominsky","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.gene.2015.08.009_bb0260","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1002\/pmic.201200261","article-title":"Temozolomide-modulated glioma proteome: role of interleukin-1 receptor-associated kinase-4 (IRAK4) in chemosensitivity","volume":"13","author":"Kumar","year":"2013","journal-title":"Proteomics"},{"key":"10.1016\/j.gene.2015.08.009_bb0265","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1593\/neo.91360","article-title":"Long-term temozolomide treatment induces marked amino metabolism modifications and an increase in TMZ sensitivity in Hs683 oligodendroglioma cells","volume":"12","author":"Lamoral-Theys","year":"2010","journal-title":"Neoplasia"},{"key":"10.1016\/j.gene.2015.08.009_bb0270","doi-asserted-by":"crossref","first-page":"e38706","DOI":"10.1371\/journal.pone.0038706","article-title":"Inhibition of mitochondria- and endoplasmic reticulum stress-mediated autophagy augments temozolomide-induced apoptosis in glioma cells","volume":"7","author":"Lin","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.gene.2015.08.009_bb0275","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0278-5846(99)00003-2","article-title":"Understanding the biological activity of amyloid proteins in vitro: from inhibited cellular MTT reduction to altered cellular cholesterol homeostatis","volume":"23","author":"Liu","year":"1999","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.gene.2015.08.009_bb0280","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s00280-009-1047-0","article-title":"MTT assays can underestimate cell numbers","volume":"64","author":"Liu","year":"2009","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.gene.2015.08.009_bb0285","doi-asserted-by":"crossref","first-page":"13266","DOI":"10.1073\/pnas.95.22.13266","article-title":"Amyloid beta peptide alters intracellular vesicle trafficking and cholesterol homeostasis","volume":"95","author":"Liu","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.gene.2015.08.009_bb0290","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1517\/13543776.2013.828695","article-title":"FK506-binding protein 12 ligands: a patent review","volume":"23","author":"Liu","year":"2013","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.gene.2015.08.009_bb0295","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/nbm.2848","article-title":"Treatment with the MEK inhibitor U0126 induces decreased hyperpolarized pyruvate to lactate conversion in breast, but not prostate, cancer cells","volume":"26","author":"Lodi","year":"2013","journal-title":"NMR Biomed."},{"key":"10.1016\/j.gene.2015.08.009_bb0300","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/nbm.3109","article-title":"MR-detectable metabolic consequences of mitogen-activated protein kinase kinase (MEK) inhibition","volume":"27","author":"Lodi","year":"2014","journal-title":"NMR Biomed."},{"key":"10.1016\/j.gene.2015.08.009_bb0305","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1002\/mnfr.201400051","article-title":"Ursolic acid triggers nonprogrammed death (necrosis) in human glioblastoma multiforme DBTRG-05MG cells through MPT pore opening and ATP decline","volume":"58","author":"Lu","year":"2014","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.gene.2015.08.009_bb0310","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s12575-009-9020-1","article-title":"Critical appraisal of the MTT assay in the presence of rottlerin and uncouplers","volume":"11","author":"Maioli","year":"2009","journal-title":"Biol. Proced. Online"},{"key":"10.1016\/j.gene.2015.08.009_bb0315","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1023\/B:CBTO.0000010396.88482.54","article-title":"Comparative evaluation of the antiproliferative effect of cyclosporin A and gamma-interferon on normal and HPV-transformed keratinocytes by cell counting, MTT assay and tritiated thymidine incorporation","volume":"13","author":"Marionnet","year":"1997","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.gene.2015.08.009_bb0320","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0014-5793(01)02651-5","article-title":"Effects of MAP kinase cascade inhibitors on the MKK5\/ERK5 pathway","volume":"502","author":"Mody","year":"2001","journal-title":"FEBS Lett."},{"key":"10.1016\/j.gene.2015.08.009_bb0325","doi-asserted-by":"crossref","first-page":"473","DOI":"10.4161\/15384101.2014.991572","article-title":"mTOR coordinates protein synthesis, mitochondrial activity and proliferation","volume":"14","author":"Morita","year":"2015","journal-title":"Cell Cycle"},{"key":"10.1016\/j.gene.2015.08.009_bb0330","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.gene.2015.08.009_bb0335","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0009-2797(00)00192-7","article-title":"Relationship of MTT reduction to stimulants of muscle metabolism","volume":"128","author":"Newman","year":"2000","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.gene.2015.08.009_bb0340","doi-asserted-by":"crossref","first-page":"39759","DOI":"10.1074\/jbc.M110.147504","article-title":"Acquisition of temozolomide chemoresistance in gliomas leads to remodeling of mitochondrial electron transport chain","volume":"285","author":"Oliva","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.gene.2015.08.009_bb0345","doi-asserted-by":"crossref","first-page":"e24665","DOI":"10.1371\/journal.pone.0024665","article-title":"Acquisition of chemoresistance in gliomas is associated with increased mitochondrial coupling and decreased ROS production","volume":"6","author":"Oliva","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.gene.2015.08.009_bb0350","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1021\/cn500288n","article-title":"U0126 protects cells against oxidative stress independent of its function as a MEK inhibitor","volume":"6","author":"Ong","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.gene.2015.08.009_bb0355","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.ccr.2011.11.004","article-title":"Nilotinib and MEK inhibitors induce synthetic lethality through paradoxical activation of RAF in drug-resistant chronic myeloid leukemia","volume":"20","author":"Packer","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.gene.2015.08.009_bb0360","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/0959-8049(93)90297-S","article-title":"Genistein inhibits tumour cell growth in vitro but enhances mitochondrial reduction of tetrazolium salts: a further pitfall in the use of the MTT assay for evaluating cell growth and survival","volume":"29A","author":"Pagliacci","year":"1993","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.gene.2015.08.009_bb0365","first-page":"5305","article-title":"Dynamin triple knockout cells reveal off target effects of commonly used dynamin inhibitors","volume":"126","author":"Park","year":"2013","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.gene.2015.08.009_bb0370","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1042\/BJ20101024","article-title":"Characterization of PF-4708671, a novel and highly specific inhibitor of p70 ribosomal S6 kinase (S6K1)","volume":"431","author":"Pearce","year":"2010","journal-title":"Biochem. J."},{"key":"10.1016\/j.gene.2015.08.009_bb0375","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.colsurfb.2005.07.014","article-title":"Reduction of MTT by flavonoids in the absence of cells","volume":"45","author":"Peng","year":"2005","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.gene.2015.08.009_bb0380","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.chemosphere.2014.01.010","article-title":"Assessment of genotoxicity and acute toxic effect of the imatinib mesylate in plant bioassays","volume":"115","author":"Pichler","year":"2014","journal-title":"Chemosphere"},{"key":"10.1016\/j.gene.2015.08.009_bb0385","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3389\/fonc.2014.00064","article-title":"Targeting PI3K\/Akt\/mTOR signaling in cancer","volume":"4","author":"Porta","year":"2014","journal-title":"Front. Oncol."},{"key":"10.1016\/j.gene.2015.08.009_bb0390","doi-asserted-by":"crossref","first-page":"7092","DOI":"10.1158\/1078-0432.CCR-09-1349","article-title":"The neuropharmacokinetics of temozolomide in patients with resectable brain tumors: potential implications for the current approach to chemoradiation","volume":"15","author":"Portnow","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.gene.2015.08.009_bb0395","series-title":"F1000Prime Rep","first-page":"52","article-title":"mTOR and lysosome regulation","volume":"6","author":"Puertollano","year":"2014"},{"key":"10.1016\/j.gene.2015.08.009_bb0400","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.3390\/ph6121475","article-title":"Glioblastoma multiforme therapy and mechanisms of resistance","volume":"6","author":"Ramirez","year":"2013","journal-title":"Pharm. (Basel)"},{"key":"10.1016\/j.gene.2015.08.009_bb0405","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1074\/jbc.M112.430082","article-title":"Acute mitochondrial inhibition by mitogen-activated protein kinase\/extracellular signal-regulated kinase kinase (MEK) 1\/2 inhibitors regulates proliferation","volume":"288","author":"Ripple","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.gene.2015.08.009_bb0410","doi-asserted-by":"crossref","first-page":"5424","DOI":"10.2174\/092986711798194333","article-title":"The emerging role of large immunophilin FK506 binding protein 51 in cancer","volume":"18","author":"Romano","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.gene.2015.08.009_bb0415","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/PPO.0b013e31823dec8d","article-title":"Evolution of therapies for chronic myelogenous leukemia","volume":"17","author":"Santos","year":"2011","journal-title":"Cancer J."},{"key":"10.1016\/j.gene.2015.08.009_bb0420","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1038\/nm1009-1158","article-title":"Shifting paradigms: the seeds of oncogene addiction","volume":"15","author":"Sawyers","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.gene.2015.08.009_bb0425","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1290\/1543-706X(2003)039<0329:ETOCCA>2.0.CO;2","article-title":"Ergovaline toxicity on Caco-2 cells as assessed by MTT, alamarBlue, and DNA assays","volume":"39","author":"Shappell","year":"2003","journal-title":"In Vitro Cell. Dev. Biol. Anim."},{"key":"10.1016\/j.gene.2015.08.009_bb0430","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nrm3757","article-title":"Making new contacts: the mTOR network in metabolism and signalling crosstalk","volume":"15","author":"Shimobayashi","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.gene.2015.08.009_bb0435","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jep.2004.04.011","article-title":"Reduction of MTT by aqueous herbal extracts in the absence of cells","volume":"93","author":"Shoemaker","year":"2004","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.gene.2015.08.009_bb0440","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s00280-009-1004-y","article-title":"MTT assays cannot be utilized to study the effects of STI571\/Gleevec on the viability of solid tumor cell lines","volume":"64","author":"Sims","year":"2009","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.gene.2015.08.009_bb0445","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0006-3002(63)90513-4","article-title":"Studies on succinate-tetrazolium reductase systems. III. Points of coupling of four different tetrazolium salts","volume":"77","author":"Slater","year":"1963","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.gene.2015.08.009_bb0450","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/BF00689967","article-title":"Assessment of antineoplastic agents by MTT assay: partial underestimation of antiproliferative properties","volume":"30","author":"Sobottka","year":"1992","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.gene.2015.08.009_bb0455","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.tips.2007.07.003","article-title":"Rottlerin: an inappropriate and ineffective inhibitor of PKCdelta","volume":"28","author":"Soltoff","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.gene.2015.08.009_bb0460","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.3109\/10428194.2012.695779","article-title":"Off-target effects of BCR-ABL1 inhibitors and their potential long-term implications in patients with chronic myeloid leukemia","volume":"53","author":"Steegmann","year":"2012","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.gene.2015.08.009_bb0465","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.gene.2014.02.053","article-title":"Karyotypically distinct U251, U373, and SNB19 glioma cell lines are of the same origin but have different drug treatment sensitivities","volume":"540","author":"Stepanenko","year":"2014","journal-title":"Gene"},{"key":"10.1016\/j.gene.2015.08.009_bb0470","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.mrfmmm.2014.12.006","article-title":"Step-wise and punctuated genome evolution drive phenotype changes of tumor cells","volume":"771","author":"Stepanenko","year":"2015","journal-title":"Mutat. Res."},{"key":"10.1016\/j.gene.2015.08.009_bb0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2015.05.018","article-title":"Development of resistance to antiglioma agents in rat C6 cells caused collateral sensitivity to doxorubicin","author":"Stojkovi\u0107","year":"2015","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.gene.2015.08.009_bb0480","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.tem.2011.08.001","article-title":"FKBP51 and FKBP52 in signaling and disease","volume":"22","author":"Storer","year":"2011","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.gene.2015.08.009_bb0485","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s11060-011-0729-8","article-title":"Protein alterations associated with temozolomide resistance in subclones of human glioblastoma cell lines","volume":"107","author":"Sun","year":"2012","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.gene.2015.08.009_bb0490","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1158\/1541-7786.MCR-12-0168","article-title":"Alkylation sensitivity screens reveal a conserved cross-species functionome","volume":"10","author":"Svilar","year":"2012","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.gene.2015.08.009_bb0495","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0197-0186(01)00097-3","article-title":"Substrate-dependence of reduction of MTT: a tetrazolium dye differs in cultured astroglia and neurons","volume":"40","author":"Takahashi","year":"2002","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.gene.2015.08.009_bb0500","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/j.febslet.2006.04.040","article-title":"Inhibition of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) endocytosis by ouabain in human endothelial cells","volume":"580","author":"Trevisi","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.gene.2015.08.009_bb0505","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000077285","article-title":"Interference by anti-cancer chemotherapeutic agents in the MTT-tumor chemosensitivity assay","volume":"50","author":"Ulukaya","year":"2004","journal-title":"Chemotherapy"},{"key":"10.1016\/j.gene.2015.08.009_bb0510","doi-asserted-by":"crossref","first-page":"e107364","DOI":"10.1371\/journal.pone.0107364","article-title":"PF-4708671 activates AMPK independently of p70S6K1 inhibition","volume":"9","author":"Vainer","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.gene.2015.08.009_bb0515","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ejps.2004.07.006","article-title":"Substrates and inhibitors of efflux proteins interfere with the MTT assay in cells and may lead to underestimation of drug toxicity","volume":"23","author":"Vellonen","year":"2004","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.gene.2015.08.009_bb0520","doi-asserted-by":"crossref","first-page":"e00969","DOI":"10.7554\/eLife.00969","article-title":"BRAF inhibitors suppress apoptosis through off-target inhibition of JNK signaling","volume":"2","author":"Vin","year":"2013","journal-title":"Elife"},{"key":"10.1016\/j.gene.2015.08.009_bb0525","first-page":"2515","article-title":"Tetrazolium-based assays for cellular viability: a critical examination of selected parameters affecting formazan production","volume":"51","author":"Vistica","year":"1991","journal-title":"Cancer Res."},{"key":"10.1016\/j.gene.2015.08.009_bb0530","doi-asserted-by":"crossref","first-page":"e10202","DOI":"10.1371\/journal.pone.0010202","article-title":"Limitations of MTT and MTS-based assays for measurement of antiproliferative activity of green tea polyphenols","volume":"5","author":"Wang","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.gene.2015.08.009_bb0535","doi-asserted-by":"crossref","first-page":"5164","DOI":"10.1021\/bi4007644","article-title":"Off-target effects of MEK inhibitors","volume":"52","author":"Wauson","year":"2013","journal-title":"Biochemistry"},{"key":"10.1016\/j.gene.2015.08.009_bb0540","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ijpharm.2004.09.018","article-title":"A practical note on the use of cytotoxicity assays","volume":"288","author":"Weyermann","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.gene.2015.08.009_bb0545","first-page":"263","article-title":"mTOR signaling from cellular senescence to organismal aging","volume":"5","author":"Xu","year":"2014","journal-title":"Aging Dis."},{"key":"10.1016\/j.gene.2015.08.009_bb0550","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s12967-014-0278-y","article-title":"A co-culture model with brain tumor-specific bioluminescence demonstrates astrocytes-induced drug resistance in glioblastoma","volume":"12","author":"Yang","year":"2014","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.gene.2015.08.009_bb0555","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080397","article-title":"Protective properties of radio-chemoresistant glioblastoma stem cell clones are associated with metabolic adaptation to reduced glucose dependence","volume":"8","author":"Ye","year":"2013","journal-title":"PLoS One"},{"issue":"622\u20134","key":"10.1016\/j.gene.2015.08.009_bb0560","first-page":"626","article-title":"Reduction of MTT by glutathione S-transferase","volume":"25","author":"York","year":"1998","journal-title":"Biotechniques"},{"key":"10.1016\/j.gene.2015.08.009_bb0565","first-page":"431","article-title":"MTT assay overestimates human airway smooth muscle cell number in culture","volume":"38","author":"Zhang","year":"1996","journal-title":"Biochem. Mol. Biol. Int."}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037811191500952X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037811191500952X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T08:44:12Z","timestamp":1718009052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037811191500952X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":114,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S037811191500952X"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2015.08.009","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pitfalls of the MTT assay: Direct and off-target effects of inhibitors can result in over\/underestimation of cell viability","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2015.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}